Top Small Cap Negative News Movers Premarket: LGVN: -55% Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel SNYR: -48% Delisting Notice DLXY: -42% Momentum Mover NAMI: -20% Momentum Mover
Top Small Cap Negative News Movers Premarket: LGVN: -55% Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel SNYR: -48% Delisting Notice DLXY: -42% Momentum Mover NAMI: -20% Momentum Mover